Teclistamab improves depth of response and PFS in high-risk smouldering multiple myeloma

ESMO 2026: Bladder and kidney cancer roundup

ESMO 2026: Prostate cancer roundup

Outpatient administration of xaluritamig for mCRPC: Feasibility and safety

Personalised neoantigen vaccine plus radiotherapy improves progression free survival in advanced solid tumours

Tarlatamab improves long term survival in previously treated small cell lung cancer

ABBV-706 shows promising antitumour activity in R/R SCLC

Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer

Zanidatamab plus chemotherapy improves overall survival in HER2-positive advanced gastroesophageal cancer

Darolutamide plus ADT and radiotherapy improves metastasis free survival in very high risk prostate cancer

ESMO 2026: Surgery in high-risk localised prostate cancer

Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC